Correction to: Cell Death & Disease
https://doi.org/10.1038/s41419-020-02912-0 published online 22 August 2020
The original version of this Article contained errors in the author affiliations.
Zhida Chen was incorrectly associated with Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, China. Haonan Li, Qiao Qiao and Qing Zhu were incorrectly associated with Department of Nephrology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
This has now been corrected in both the PDF and HTML versions of the Article.
Edited by F. Pentimalli
The original article can be found online at https://doi.org/10.1038/s41419-020-02912-0.
About this article
Cite this article
Chen, Z., Wu, C., Liu, Y. et al. Correction: ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway. Cell Death Dis 11, 905 (2020). https://doi.org/10.1038/s41419-020-02933-9